Amy Rabourn
Treasurer presso OCUPHIRE PHARMA, INC.
Patrimonio netto: - $ in data 30/04/2024
Profilo
Amy Rabourn is currently the Treasurer & Senior Vice President-Finance at Ocuphire Pharma, Inc. Prior to her current position, she worked as the Finance Director at Gemphire Therapeutics, Inc. from 2014 to 2019.
Ms. Rabourn has an undergraduate and graduate degree from the University of Michigan.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
OCUPHIRE PHARMA, INC.
-.--% | 10/04/2023 | 0 ( -.--% ) | - $ | 30/04/2024 |
Posizioni attive di Amy Rabourn
| Società | Posizione | Inizio |
|---|---|---|
| OCUPHIRE PHARMA, INC. | Treasurer | - |
Precedenti posizioni note di Amy Rabourn
| Società | Posizione | Fine |
|---|---|---|
| NEUROBO PHARMACEUTICALS, INC. | Director of Finance/CFO | 01/12/2019 |
Formazione di Amy Rabourn
| University of Michigan | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| OCUPHIRE PHARMA, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Gemphire Therapeutics, Inc.
 Gemphire Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Gemphire Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics of dyslipidemia, as well as non-alcoholic fatty liver disease. It offers a small molecule formulated as a tablet product under the Gemcabene brand. The company was founded by Charles L. Bisgaier and David Lowenschuss on October 30, 2014 and is headquartered in Livonia, MI. | Health Technology |
- Borsa valori
- Insiders
- Amy Rabourn
